After the purchase concludes, the firm intends to include PRISM Vision into its U.S. Pharmaceutical division subject to ...

MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States.

德克萨斯州欧文 - 根据 InvestingPro 指标显示财务状况"优异"的760亿美元医疗保健巨头McKesson Corporation（NYSE: MCK）已达成最终协议，将以约8.5亿美元收购眼科和视网膜管理服务提供商PRISM Vision Holdings, LLC的80%股权。根据交易条款，PRISM Vision的医生将保留公司20%的权益。

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

McKesson expects PRISM Vision to add about 20 cents to 30 cents to its adjusted earnings per share in the first 12 months following the close of the transaction, and then to be between 65 cents and 75 ...

McKesson acquires 80% of PRISM Vision Holdings for $850M, expanding their presence in ophthalmology and retina management services.

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

McKesson (NYSE:MCK), a diversified healthcare services company, has announced plans to acquire an 80% stake in PRISM Vision ...

McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.

IRVING, Texas - McKesson Corporation (NYSE: NYSE:MCK), a $76 billion healthcare giant with "GREAT" financial health according to InvestingPro metrics, has entered into a definitive agreement to ...

McKesson (MCK) signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, a provider of general ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...